Search Results 401-410 of 17356 for Break STD Taboo

1. Gastroenterology and Hepatology - Clinical trials

   ... standard of care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. The primary study hypothesis is that pembrolizumab will ...

2. 9-13 Q & A Podcast COVID-19 Update - Mayo Clinic News Network

   ... standard regimen will be three doses. Whereas maybe if you're younger, the standard regimen might be two doses, just like HPV vaccine, in fact, may well ...

3. A Study of the Prevalence of Probable and Diagnosed REM Sleep Behavior Disorder - Mayo Clinic

   The purpose of this study is to determine the frequency of sleep behavior disorder by age group and sex in Olmsted County MN. Participation eligibility.

4. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

5. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

6. Sex Differences in OSA - Clinical Trials

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

7. blood test Archives - Mayo Clinic News Network

   ... breaking advancement and could have a tremendous human and economic benefit.” Initial results from the interventional PATHFINDER Study, which involved the ...

8. A Study To Assess The Feasibility And Safety Of Intratumoral Diffusing Alpha Emitters For The Treatment Of Recurrent Glioblastoma - Mayo Clinic

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

9. Clinical trials - Gastroenterology and Hepatology

   ... standard of care chemotherapy in participants with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). Cohort of Patients With Fatty ...

10. Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...